Sale!

CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CACNA1D gene plays a crucial role in the proper functioning of the sinoatrial node, which is responsible for initiating the heart’s rhythm, as well as in hearing processes. Mutations in the CACNA1D gene can lead to sinoatrial node dysfunction and deafness, a rare genetic disorder characterized by an irregular heart rhythm and hearing loss. To diagnose this condition, a specific genetic test is available at DNA Labs UAE, designed to identify mutations in the CACNA1D gene. This test is essential for individuals experiencing symptoms related to heart rhythm irregularities and hearing impairment, or for those with a family history of the condition, as it can provide a definitive diagnosis. The test is priced at 4400 AED and offers a crucial step towards personalized treatment and management plans for affected individuals.

Description

CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test

Test Name: CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CACNA1D Gene Sinoatrial Node Dysfunction and Deafness NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1D Gene Sinoatrial Node Dysfunction and Deafness NGS Genetic DNA Test gene CACNA1D

Test Details: The CACNA1D gene is associated with both sinoatrial node dysfunction and deafness. Sinoatrial node dysfunction refers to abnormalities in the electrical conduction system of the heart, specifically affecting the sinoatrial node, which is responsible for initiating the heart’s electrical signals. This dysfunction can lead to irregular heart rhythms, such as bradycardia (slow heart rate) or sinus arrest (pauses in the heart’s electrical activity). Deafness, on the other hand, refers to partial or complete loss of hearing. Mutations in the CACNA1D gene have been linked to a specific form of deafness called autosomal dominant non-syndromic hearing loss type 23 (DFNA23). This type of hearing loss typically begins in late childhood or early adulthood and affects both ears equally.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations associated with specific conditions. In the context of the CACNA1D gene, NGS genetic testing can be used to identify any mutations or variations in this gene that may be causing sinoatrial node dysfunction or deafness. This information can then be used for diagnosis, prognosis, and potentially guiding treatment decisions.

Test Name	CACNA1D Gene Sinoatrial node dysfunction and deafness Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CACNA1D Gene Sinoatrial node dysfunction and deafness NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1D Gene Sinoatrial node dysfunction and deafness NGS Genetic DNA Test gene CACNA1D
Test Details	The CACNA1D gene is associated with both sinoatrial node dysfunction and deafness. Sinoatrial node dysfunction refers to abnormalities in the electrical conduction system of the heart, specifically affecting the sinoatrial node, which is responsible for initiating the heart’s electrical signals. This dysfunction can lead to irregular heart rhythms, such as bradycardia (slow heart rate) or sinus arrest (pauses in the heart’s electrical activity). Deafness, on the other hand, refers to partial or complete loss of hearing. Mutations in the CACNA1D gene have been linked to a specific form of deafness called autosomal dominant non-syndromic hearing loss type 23 (DFNA23). This type of hearing loss typically begins in late childhood or early adulthood and affects both ears equally. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations associated with specific conditions. In the context of the CACNA1D gene, NGS genetic testing can be used to identify any mutations or variations in this gene that may be causing sinoatrial node dysfunction or deafness. This information can then be used for diagnosis, prognosis, and potentially guiding treatment decisions.